MA
ACLX

MYDA Advisors’s Arcellx ACLX Stock Holding History

MYDA Advisors’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$835K – 132
2024
Q3 		$835K Sell
10,000
-32,000
-76% -$2.13M 0.18% 89
2024
Q2 		$2.32M Buy
42,000
+7,000
+20% +$381K 0.5% 47
2024
Q1 		$2.43M Sell
35,000
-5,000
-13% -$317K 0.7% 41
2023
Q4 		$2.22M Buy
40,000
+15,000
+60% +$677K 0.74% 37
2023
Q3 		$897K Buy
+25,000
New +$862K 0.29% 56
2023
Q2 		– Sell
-8,000
Closed -$246K – 120
2023
Q1 		$246K Hold
8,000
– – 0.09% 94
2022
Q4 		$248K Sell
8,000
-2,000
-20% -$45.9K 0.15% 68
2022
Q3 		$188K Buy
+10,000
New +$191K 0.09% 119

Other funds holding ACLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MYDA Advisors's ACLX Position: Q4 2024 in Review

MYDA Advisors sold out of Arcellx (ACLX) in Q4 2024, closing a stake of 10,000 shares — an estimated $835K sold.

MYDA Advisors first reported a position in ACLX in Q3 2022 and held it in 8 quarters. The position peaked at $2.43M in Q1 2024. 211 funds tracked by Wall St. Rank hold ACLX as of Q4 2024.

  • MYDA Advisors reported no remaining Arcellx position as of Q4 2024 after selling out during the quarter.
  • MYDA Advisors sold 10,000 Arcellx shares in Q4 2024, an estimated $835K.
  • MYDA Advisors first reported a position in Arcellx in Q3 2022 and held it in 8 quarters.
  • MYDA Advisors's Arcellx position peaked at $2.43M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Arcellx as of Q4 2024.

Based on MYDA Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.